PRKCA and non-small cell lung carcinoma: Curcumin constrained the abnormal proliferation and differentiation of NSCLC cells by inhibiting the circ-PRKCA/miR-384/ITGB1 pathway and adjusting and controlling ITGB1 expression via adsorbing miR-384 [33].